Cinctive Capital Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-108,022
Closed -$697K 398
2025
Q3
$697K Buy
+108,022
New +$738K 0.03% 328
2025
Q1
Sell
-222,348
Closed -$1.79M 329
2024
Q4
$1.79M Buy
222,348
+138,638
+166% +$1.14M 0.09% 231
2024
Q3
$683K Buy
83,710
+17,233
+26% +$114K 0.04% 321
2024
Q2
$463K Buy
66,477
+21,826
+49% +$165K 0.02% 353
2024
Q1
$474K Buy
+44,651
New +$390K 0.02% 344
2022
Q1
Sell
-89,560
Closed -$2.47M 524
2021
Q4
$2.47M Sell
89,560
-18,440
-17% -$494K 0.11% 271
2021
Q3
$3.01M Buy
+108,000
New +$3.06M 0.15% 238
2021
Q1
Sell
-140,022
Closed -$2.91M 410
2020
Q4
$2.91M Buy
+140,022
New +$2.61M 0.24% 176

Other funds holding BHC

Cinctive Capital Management's BHC Position: Q4 2025 in Review

Cinctive Capital Management sold out of Bausch Health (BHC) in Q4 2025, closing a stake of 108,022 shares — an estimated $697K sold.

Cinctive Capital Management first reported a position in BHC in Q4 2020 and held it in 8 quarters. The position peaked at $3.01M in Q3 2021. 236 funds tracked by Wall St. Rank hold BHC as of Q4 2025.

  • Cinctive Capital Management reported no remaining Bausch Health position as of Q4 2025 after selling out during the quarter.
  • Cinctive Capital Management sold 108,022 Bausch Health shares in Q4 2025, an estimated $697K.
  • Cinctive Capital Management first reported a position in Bausch Health in Q4 2020 and held it in 8 quarters.
  • Cinctive Capital Management's Bausch Health position peaked at $3.01M in Q3 2021.
  • 236 funds tracked by Wall St. Rank held Bausch Health as of Q4 2025.

Based on Cinctive Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.